Physostigmine salicylate, a cholinesterase inhibitor, has been shown to reverse the effects of certain drugs with anticholinergic properties. The paper provides a brief historical account of physostigmine, reviews the cholinergic drugs and their effects and suggests a management protocol based on physiologic criteria. Twenty-six overdose cases, recently treated with physostigmine, are summarized. The controversy regarding the etiology of seizures following physostigmine administration is discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0361-1124(76)80253-5 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!